RUXMEOR Trademark

Trademark Overview


On Monday, July 2, 2018, a trademark application was filed for RUXMEOR with the United States Patent and Trademark Office. The USPTO has given the RUXMEOR trademark a serial number of 88023074. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 8, 2021. This trademark is owned by Pfizer Inc.. The RUXMEOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
ruxmeor

General Information


Serial Number88023074
Word MarkRUXMEOR
Filing DateMonday, July 2, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 7, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, March 8, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 8, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 24, 2020EXTENSION 3 GRANTED
Friday, July 24, 2020EXTENSION 3 FILED
Friday, July 24, 2020TEAS EXTENSION RECEIVED
Tuesday, January 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 10, 2020EXTENSION 2 GRANTED
Friday, January 10, 2020EXTENSION 2 FILED
Friday, January 10, 2020TEAS EXTENSION RECEIVED
Thursday, August 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2019EXTENSION 1 GRANTED
Tuesday, July 30, 2019EXTENSION 1 FILED
Tuesday, July 30, 2019TEAS EXTENSION RECEIVED
Tuesday, February 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 11, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 23, 2018ASSIGNED TO EXAMINER
Saturday, July 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 5, 2018NEW APPLICATION ENTERED IN TRAM